Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide

Using a one-step thermal reduction and non-covalent chemical functionalization process, PEGylated reduced nanographene oxide (rGOn-PEG) was produced from nanographene oxide (GOn) and characterized in terms of particle size, dispersion stability, chemistry, and photothermal properties, in view of its...

Full description

Bibliographic Details
Main Authors: Raquel Costa-Almeida, Diana Bogas, José R. Fernandes, Licínia Timochenco, Filipa A. L. S. Silva, João Meneses, Inês C. Gonçalves, Fernão D. Magalhães, Artur M. Pinto
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Polymers
Subjects:
Online Access:https://www.mdpi.com/2073-4360/12/8/1840
_version_ 1797557605496782848
author Raquel Costa-Almeida
Diana Bogas
José R. Fernandes
Licínia Timochenco
Filipa A. L. S. Silva
João Meneses
Inês C. Gonçalves
Fernão D. Magalhães
Artur M. Pinto
author_facet Raquel Costa-Almeida
Diana Bogas
José R. Fernandes
Licínia Timochenco
Filipa A. L. S. Silva
João Meneses
Inês C. Gonçalves
Fernão D. Magalhães
Artur M. Pinto
author_sort Raquel Costa-Almeida
collection DOAJ
description Using a one-step thermal reduction and non-covalent chemical functionalization process, PEGylated reduced nanographene oxide (rGOn-PEG) was produced from nanographene oxide (GOn) and characterized in terms of particle size, dispersion stability, chemistry, and photothermal properties, in view of its use for photothermal therapy (PTT) of non-melanoma skin cancer. GOn infrared spectrum presented more intense bands assigned to oxygen containing functional groups than observed for rGOn-PEG. GOn C/O ratio decreased more than 50% comparing with rGOn-PEG and nitrogen was present in the latter (N <i>at</i> % = 20.6) due to introduction of PEG-NH<sub>2</sub>. Thermogravimetric analysis allowed estimating the amount of PEG in rGOn-PEG to be of about 56.1%. Simultaneous reduction and PEGylation increased the lateral dimensions from 287 ± 139 nm to 521 ± 397 nm, as observed by transmission electron microscopy and dynamic light scattering. rGOn-PEG exhibited ≈13-fold higher absorbance in the near-infrared radiation (NIR) region, as compared to unmodified GOn. Low power (150 mW cm<sup>−2</sup>) NIR irradiation using LEDs resulted in rGOn-PEG heating up to 47 °C, which is within the mild PTT temperature range. PEGylation strongly enhanced the dispersibility of rGOn in physiological media (phosphate buffered saline, fetal bovine serum, and cell culture medium) and also improved the biocompatibility of rGOn-PEG, in comparison to GOn (25–250 μg mL<sup>−1</sup>). After a single NIR LED irradiation treatment of 30 min, a decrease of ≈38% in A-431 cells viability was observed for rGOn-PEG (250 μg mL<sup>−1</sup>). Together, our results demonstrate the potential of irradiating rGOn-PEG using lower energy, cheaper, smaller, and safer LEDs, as alternative to high power lasers, for NIR mild hyperthermia therapy of cancer, namely non-melanoma skin cancer.
first_indexed 2024-03-10T17:19:12Z
format Article
id doaj.art-5d7e7ec691684bd7a46bb3afd2beb959
institution Directory Open Access Journal
issn 2073-4360
language English
last_indexed 2024-03-10T17:19:12Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Polymers
spelling doaj.art-5d7e7ec691684bd7a46bb3afd2beb9592023-11-20T10:23:37ZengMDPI AGPolymers2073-43602020-08-01128184010.3390/polym12081840Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene OxideRaquel Costa-Almeida0Diana Bogas1José R. Fernandes2Licínia Timochenco3Filipa A. L. S. Silva4João Meneses5Inês C. Gonçalves6Fernão D. Magalhães7Artur M. Pinto8i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-180 Porto, PortugalLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-180 Porto, PortugalCQVR—Centro de Química Vila Real, Departamento de Física, ECT, Universidade de Trás-os-Montes e Alto Douro, 5001-801 Vila Real, PortugalLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-180 Porto, Portugali3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-180 Porto, PortugalLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-180 Porto, Portugali3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-180 Porto, PortugalLEPABE, Faculdade de Engenharia, Universidade do Porto, 4200-180 Porto, Portugali3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-180 Porto, PortugalUsing a one-step thermal reduction and non-covalent chemical functionalization process, PEGylated reduced nanographene oxide (rGOn-PEG) was produced from nanographene oxide (GOn) and characterized in terms of particle size, dispersion stability, chemistry, and photothermal properties, in view of its use for photothermal therapy (PTT) of non-melanoma skin cancer. GOn infrared spectrum presented more intense bands assigned to oxygen containing functional groups than observed for rGOn-PEG. GOn C/O ratio decreased more than 50% comparing with rGOn-PEG and nitrogen was present in the latter (N <i>at</i> % = 20.6) due to introduction of PEG-NH<sub>2</sub>. Thermogravimetric analysis allowed estimating the amount of PEG in rGOn-PEG to be of about 56.1%. Simultaneous reduction and PEGylation increased the lateral dimensions from 287 ± 139 nm to 521 ± 397 nm, as observed by transmission electron microscopy and dynamic light scattering. rGOn-PEG exhibited ≈13-fold higher absorbance in the near-infrared radiation (NIR) region, as compared to unmodified GOn. Low power (150 mW cm<sup>−2</sup>) NIR irradiation using LEDs resulted in rGOn-PEG heating up to 47 °C, which is within the mild PTT temperature range. PEGylation strongly enhanced the dispersibility of rGOn in physiological media (phosphate buffered saline, fetal bovine serum, and cell culture medium) and also improved the biocompatibility of rGOn-PEG, in comparison to GOn (25–250 μg mL<sup>−1</sup>). After a single NIR LED irradiation treatment of 30 min, a decrease of ≈38% in A-431 cells viability was observed for rGOn-PEG (250 μg mL<sup>−1</sup>). Together, our results demonstrate the potential of irradiating rGOn-PEG using lower energy, cheaper, smaller, and safer LEDs, as alternative to high power lasers, for NIR mild hyperthermia therapy of cancer, namely non-melanoma skin cancer.https://www.mdpi.com/2073-4360/12/8/1840graphenelight emitting diodephototherapypolyethylene glycolthermal reduction
spellingShingle Raquel Costa-Almeida
Diana Bogas
José R. Fernandes
Licínia Timochenco
Filipa A. L. S. Silva
João Meneses
Inês C. Gonçalves
Fernão D. Magalhães
Artur M. Pinto
Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide
Polymers
graphene
light emitting diode
phototherapy
polyethylene glycol
thermal reduction
title Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide
title_full Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide
title_fullStr Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide
title_full_unstemmed Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide
title_short Near-Infrared Radiation-Based Mild Photohyperthermia Therapy of Non-Melanoma Skin Cancer with PEGylated Reduced Nanographene Oxide
title_sort near infrared radiation based mild photohyperthermia therapy of non melanoma skin cancer with pegylated reduced nanographene oxide
topic graphene
light emitting diode
phototherapy
polyethylene glycol
thermal reduction
url https://www.mdpi.com/2073-4360/12/8/1840
work_keys_str_mv AT raquelcostaalmeida nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT dianabogas nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT joserfernandes nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT liciniatimochenco nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT filipaalssilva nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT joaomeneses nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT inescgoncalves nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT fernaodmagalhaes nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide
AT arturmpinto nearinfraredradiationbasedmildphotohyperthermiatherapyofnonmelanomaskincancerwithpegylatedreducednanographeneoxide